BKR Q1 FY2026 Earnings: $9.5B Mandatory Redemption Trip-Wire

On March 11, 2026, Baker Hughes Company (Nasdaq: BKR) priced $10 billion of new senior notes to fund the $13.6 billion Chart Industries acquisition. The Q1 FY2026 10-Q (accession 0001701605-26-000014, filed April 24, 2026) reveals what that decision cost shareholders: total debt rose 166% to $16.16 billion; $9.5 billion of those notes carries a special mandatory redemption clause tied to a July 28, 2026 closing deadline not disclosed in the 8-K; buybacks were zero for the third consecutive quarter; and GAAP free cash flow fell 60% year-over-year to $164 million — the lowest FCF margin in eight quarters — at the precise moment leverage is rising.

The Deal Architecture the Press Release Glossed Over

Baker Hughes built the Chart funding stack in three steps: a $14.9 billion bridge facility on July 28, 2025; a $2.6 billion Delayed-Draw Term Loan ("DDTL") on August 15, 2025 that cut the bridge to $12.3 billion; and on March 11, 2026, $6.5 billion in USD notes (4.050%–5.850%, 2029–2056) plus €3.0 billion in Euro notes (3.226%–4.737%, 2030–2046) — Baker Hughes' inaugural Euro bond offering — retiring the remaining bridge commitment.

The mandatory redemption mechanism is the disclosure the press-release narrative did not surface. The 10-Q's debt footnote spells out the trigger language verbatim:

Two consequences for retail shareholders. First, the bond market has already underwritten the deal — investors bought $9.5 billion at coupons of 4%–5.85% knowing they receive principal back at par if the deal slips. Second, regulatory delay has a balance-sheet cost: a triggered redemption forces Baker Hughes to fund a $9.5 billion par payment on a tight clock, with coupons accruing until redemption. Baker Hughes priced approximately $9.5 billion of senior notes on March 11, 2026 with a special mandatory redemption clause tied to a July 28, 2026 Chart closing deadline — not disclosed in the Q1 8-K or the prepared remarks, and the single most material deal-execution risk in the filing.

What the 131% Net Income Surge Hides

The 8-K headline is real but narrow: GAAP net income $930 million (+131% Y/Y), GAAP EPS $0.93 (+132%). The gap is explained in the 10-Q: other (income) expense, net was $(588) million, "primarily related to $721 million gain on business dispositions" — the PSI sale to Crane and the SPC joint venture with Cactus, both closed early January. Adjusted net income excluding the disposition gain was $573 million, +12% year-over-year — exactly in line with adjusted EBITDA growth. The headline is genuine operational improvement plus a one-time gain that will not repeat.

The cash-generation engine moved in the opposite direction. Operating cash flow was $500 million, down 29.5% from $709 million in Q1 2025. The MD&A attributes the decline to "net working capital cash usage [of] $173 million" (versus $218M of generation in Q1 2025) and lists severance payments of $55 million (up from $32 million, +72% year-over-year) within operating cash flow. MetricDuck's GAAP-defined free cash flow — operating cash flow minus the $336 million of capex — was $164 million, down 60% from $409 million in Q1 2025 and down 87% sequentially from $1.28 billion in Q4 2025. The FCF margin of 2.49% is the lowest in eight quarters. The 8-K's "free cash flow of $210 million" uses a non-GAAP definition that nets capex against $46 million of asset-disposal proceeds; both numbers are accurate within their definitions.

The CFO acknowledged the customer-payment drag in the prepared remarks:

That remark connects directly to the 10-Q's new high-severity risk-factor entry "Customer delays in payment impacting liquidity" and to the Mexico CDS hedge discussion in the next section. Baker Hughes' GAAP free cash flow fell 60% year-over-year to $164 million in Q1 2026 — the lowest FCF margin in eight quarters at 2.49% — while headline GAAP net income surged 131% on a one-time $721 million dispositions gain.

Capital Return on Pause

The 10-Q's MD&A makes the pivot explicit. Baker Hughes raised the per-share dividend by zero cents to $0.23 in Q1 2026, versus a two-cent raise in Q1 2025 — the first flat quarter in recent memory. Total dividends paid were $228 million versus $229 million the prior year. The repurchase line is starker: zero shares repurchased during Q1 2026, versus 4.4 million shares for $188 million in Q1 2025. This is the third consecutive quarter of zero buybacks — approximately $750 million of annualized buyback capacity removed from the capital-return mix.

Where did that capital go? Into the Chart funding pool: U.S. cash rose from $0.7 billion to $12.5 billion in a single quarter, with the MD&A stating it is "being held for the pending Chart acquisition." Net debt improved from -$2.38 billion to -$1.40 billion, but the improvement is mechanical — the $10 billion debt issuance was matched almost dollar-for-dollar by earmarked cash. Pro-forma at deal close, that cash funds the $13.6 billion enterprise value, leaving gross debt in place. Management targets Net Debt / EBITDA of 1.0x–1.5x within 24 months (versus 0.3x pre-close), with deleveraging dependent on FCF recovery and $1.6 billion of expected divestiture proceeds (Waygate/Hexagon ~$1.45B; HMH IPO ~$200M). Baker Hughes held dividends flat at $0.23/share and zero buybacks for three consecutive quarters, redirecting ~$750 million of annualized buyback capacity toward the $13.6 billion Chart Industries deal.

How BKR Stacks Against Peers

Baker Hughes' agent-selected peer set is SLB (closest direct comp on services + digital + new-energy at similar global scale), Halliburton (HAL — pure-play oilfield services rival), TechnipFMC (FTI — best comp for the IET equipment + aftermarket model), NOV (capital equipment for upstream oil & gas), and Weatherford International (WFRD — smaller oilfield-services rival). The following trailing-twelve-month comparison uses MetricDuck's consolidated metrics, with a flag noted below.

*Operating margin and ROIC for both BKR (89.39% / 85.76%) and SLB (95.00% / 48.28%) are inflated by a known MetricDuck calculation discontinuity — cost of revenue dropped out of the operating-expense aggregation in newer quarters. For apples-to-apples comparability, the company-reported adjusted EBITDA margin of 17.6% for BKR Q1 2026 is the right comparator; HAL/FTI/NOV/WFRD numbers in the table are clean. SLB's -41.86% revenue growth is also a likely data anomaly. We name the limitation rather than hide it.

The peer-relative read: Baker Hughes' TTM revenue of $27.89 billion is the largest in the cohort, ahead of HAL ($22.17B) and SLB ($20.97B). Three-year revenue CAGR of 8.17% places BKR second to FTI's 14.02% and well ahead of every other peer. P/E of 19.32x sits between SLB (16.13x, cheapest) and HAL (21.42x), with NOV at 40.08x and WFRD at 14.73x — middle-of-pack on multiples. The Net Debt / EBITDA of 0.10x is the strongest balance-sheet snapshot in the group at the reporting date — but this is a snapshot reading captured before the $10 billion debt issuance flows fully through trailing EBITDA. Pro-forma at deal close, BKR's leverage moves from best-in-class to mid-pack at 2.25x net (per management's stated path), and BKR adds a bond-maturity ladder (2029–2056) and a refinancing schedule that none of these peers carry at this scale.

No peer in the cohort is currently executing a $13.6 billion acquisition with $10 billion of newly issued senior notes carrying a special mandatory redemption clause. Read against this set, BKR offers the largest revenue base and second-best 3-year growth (+8.17% CAGR) with +140 basis points Y/Y of adjusted EBITDA margin expansion — but layered on single-name deal execution risk that SLB, HAL, FTI, NOV, and WFRD do not carry.

Peers: SLB, HAL, FTI, NOV, WFRD (selected by business-model overlap — oilfield services, equipment manufacturing, and integrated industrial-energy portfolios) — source: agent.

Mexico Receivables and the Aeroderivative Bottleneck

Two risks the 10-Q quantifies that the 8-K does not. First: the Mexico customer credit-default-swap (CDS) hedge. Baker Hughes holds CDS on borrowings provided to its primary customer in Mexico, used to pay BKR's receivables. Notional balances: $514 million original ($775M at year-end 2025) and $159 million remaining ($287M at year-end 2025). The CDS amortizes monthly through September 2026, after which the exposure is unhedged. The 10-Q does not name the customer, but the scale and geography point to Pemex.

The filing-index signal layer lists "Customer delays in payment impacting liquidity" at high severity as a new entry this quarter — the 10-Q's explicit disclosure backing the CFO's "delays in customer payments" remark. The CDS expires September 2026 precisely as the post-Chart leverage profile is at its peak.

Second: the IET supply-chain bottleneck. IET booked record orders of $4.9 billion (third consecutive quarter above $4B); RPO stood at $33.1 billion (fifth consecutive quarter at this level); segment EBITDA grew 35% year-over-year to $678 million with 310-basis-point margin expansion to 20.2%. A new risk-factor entry flags "continued tightness in aeroderivative supply chain" at medium severity — the gating constraint on how quickly IET converts backlog to revenue. The CEO noted aeroderivative headwinds continuing into Q2, with normalization targeted for the second half of 2026. Baker Hughes' Q1 2026 IET segment booked record orders of $4.9 billion against $33.1 billion of remaining performance obligations, while flagging aeroderivative supply-chain tightness as the constraint on backlog conversion — order strength and revenue conversion rate are temporarily decoupled.

What This Means for BKR Shareholders

Three things for a BKR shareholder to hold. First, the operational beat is real: adjusted EBITDA $1.16 billion (+12% Y/Y), margin 17.6% (+140 basis points Y/Y), IET orders $4.9 billion (record), book-to-bill 1.5x. The 10-Q confirms the 8-K story. Second, GAAP net income +131% Y/Y is largely a one-time $721 million dispositions gain — adjusted net income +12% is the right comparison. Third, and most material, the 10-Q reveals a deal-funding architecture the press release omitted: $9.5 billion in mandatory-redemption notes with a July 28, 2026 close deadline; capital return paused for three consecutive quarters; FCF at the lowest margin in eight quarters; and a Mexico CDS hedge expiring September 2026 into peak leverage.

Peer-relative: BKR's 19.32x P/E is ~20% above SLB's 16.13x on the cohort's largest revenue base (+8.17% 3-year CAGR). That premium does not yet reflect the $9.5 billion mandatory-redemption clock or the post-close move from 0.10x to ~2.25x net leverage — both Q2/Q3 storylines. Management's competitive cluster (Boom Supersonic, Hitachi Energy, Google Cloud, ST LNG, Marathon Petroleum) is uniformly partnerships with zero displacement mentions — consistent with IET's pivot toward data-center power and AI infrastructure.

Not investment advice — analysis of SEC filings, earnings calls, and press releases.

Frequently Asked Questions

Did Baker Hughes beat Q1 2026 earnings?

Yes. Baker Hughes reported Q1 FY2026 revenue of $6.587 billion (+2% year-over-year, -11% sequentially) and adjusted EBITDA of $1,158 million (+12% year-over-year), both above the company's prior guidance range. GAAP diluted EPS was $0.93 and adjusted diluted EPS was $0.58. Free cash flow per the 8-K release was $210 million, though MetricDuck's GAAP-defined free cash flow (operating cash flow minus capex) was $164M, down 60% year-over-year from $409M in Q1 2025.

What is the $9.5 billion special mandatory redemption clause in BKR's notes?

On March 11, 2026, Baker Hughes priced $6.5 billion of USD-denominated notes and €3.0 billion of Euro-denominated notes — roughly $10 billion of new senior unsecured notes. The 10-Q footnote on debt discloses that approximately $9.5 billion of these notes are subject to a special mandatory redemption at the full aggregate principal amount plus accrued interest if (i) the Chart Industries acquisition does not close by July 28, 2026 (or the merger agreement's outside date as extended), (ii) the merger agreement is terminated, or (iii) the Company decides not to pursue the transaction. Failure to redeem when triggered would constitute an event of default. This clause does not appear in the 8-K earnings release narrative or the prepared remarks.

How much did Baker Hughes' total debt rise this quarter?

Total debt rose from $6.087 billion at December 31, 2025 to $16.164 billion at March 31, 2026 — an increase of $10.077 billion, or 166% in a single quarter. The increase was driven by the March 11, 2026 issuance of $6.5 billion in USD notes and €3.0 billion in Euro notes earmarked for the pending Chart acquisition. Cash and cash equivalents rose in tandem from $3.71 billion to $14.76 billion, with $12.5 billion now held in the United States (versus $0.7 billion at year-end 2025), explicitly disclosed as "being held for the pending Chart acquisition."

Why did Baker Hughes' free cash flow fall 60% year-over-year?

MetricDuck's GAAP free cash flow (operating cash flow minus capex) for Q1 2026 was $164 million, versus $409 million in Q1 2025 — a 60% year-over-year decline. The 10-Q's MD&A attributes the operating-cash-flow drop ($500M vs $709M, -29.5%) to net working capital usage of $173 million (versus $218M of generation in Q1 2025), driven by accounts payable payments and contract assets build-up. Severance payments rose to $55 million from $32 million (+72% year-over-year). The CFO's prepared remarks noted that "this period was further affected by some delays in customer payments."

Did Baker Hughes raise its dividend or buy back stock in Q1 2026?

No on both counts. The Q1 2026 quarterly dividend held flat at $0.23 per share — a zero-cent increase, breaking the prior year's two-cent raise pattern (Q1 2025 raised the dividend by two cents to $0.23). Total dividends paid were $228 million versus $229 million in Q1 2025. Baker Hughes did not repurchase any Class A common stock during Q1 2026, marking the third consecutive quarter of zero buybacks, versus $188 million repurchased in Q1 2025. Approximately $750M of annual buyback capacity has been redirected toward Chart funding.

How does Baker Hughes' Q1 performance compare to SLB, HAL, FTI, NOV, and WFRD?

On TTM revenue, Baker Hughes ($27.89B) is the largest in the cohort, ahead of HAL ($22.17B) and SLB ($20.97B). Revenue growth +0.20% Y/Y trails FTI (+9.35%) but beats HAL (-1.72%), NOV (-1.42%), and WFRD (-8.81%); SLB's reported -41.86% appears to be a data anomaly. Three-year revenue CAGR of 8.17% is second to FTI's 14.02%. P/E of 19.32x sits between SLB (16.13x, cheapest) and HAL (21.42x). Net Debt/EBITDA of 0.10x is the strongest of the set — but this snapshot precedes the Chart-deal $10 billion debt issuance flowing fully through trailing EBITDA; pro-forma post-close leverage will rise to roughly 2.25x per management's stated target.

What is the Mexico customer credit-default-swap exposure?

Baker Hughes' 10-Q discloses credit-default swaps with third-party financial institutions covering borrowings provided to its primary customer in Mexico. Original notional balances were $514 million at March 31, 2026 (down from $775 million at December 31, 2025); the remaining notional was $159 million (down from $287 million). The CDS amortizes monthly through September 2026 as the customer repays the borrowings. After September 2026, Baker Hughes is unhedged on this concentrated counterparty receivables exposure. The 10-Q does not name the customer.

What is the Chart Industries acquisition and when will it close?

On July 28, 2025, Baker Hughes signed a definitive agreement to acquire Chart Industries (NYSE: GTLS) for $210 per share in cash, equivalent to a total enterprise value of approximately $13.6 billion. Per the CFO's prepared remarks: "With regulatory reviews still underway in certain jurisdictions, we currently expect closing in the second quarter, understanding that the timing may evolve as those processes progress." The Integration Management Office, led by Jim Apostolides, has identified more than 250 synergy opportunities and remains targeting $325 million of cost synergies.

How was IET's quarter and what is the aeroderivative supply chain issue?

Industrial & Energy Technology (IET) booked record orders of $4.9 billion in Q1 2026 (the third consecutive quarter above $4 billion) and ended the quarter with remaining performance obligations of $33.1 billion (the fifth consecutive quarter at this level). IET segment revenue rose 14% year-over-year to $3.35 billion, with EBITDA up 35% to $678 million and margins expanding 310 basis points to 20.2%. The risk landscape signals "continued tightness in aeroderivative supply chain" — the supply-chain headwind constrains how quickly IET can convert backlog to revenue. IET orders over the trailing four quarters totaled $16.6 billion, up 25% year-over-year.

What divestiture proceeds is Baker Hughes expecting in 2026?

The CEO's prepared remarks state Baker Hughes expects approximately $3 billion in gross divestiture proceeds in 2026, comprising: $1.15 billion from the previously announced sale of Precision Sensors & Instrumentation (PSI) to Crane Company (closed early January); $344.5 million from the joint venture with Cactus, Inc. for the Surface Pressure Control product line (closed early January, with BKR retaining a 35% noncontrolling interest); approximately $1.45 billion from the announced sale of Waygate Technologies to Hexagon (April 2026); and approximately $200 million from HMH's IPO (April 2026). The CFO described the company achieving its "$1 billion incremental divestment target ahead of schedule."

Methodology

This analysis is sourced from Baker Hughes' Q1 FY2026 10-Q (accession 0001701605-26-000014, filed 2026-04-24), the Q1 FY2026 8-K earnings release (accession 0001701605-26-000012, filed 2026-04-23), the Q1 FY2026 earnings conference call prepared remarks (Q4CDN PDF, dated 2026-04-23), and MetricDuck's computed financial metrics derived from SEC EDGAR XBRL facts. Peer metrics are MetricDuck's consolidated trailing-twelve-month values for SLB, HAL, FTI, NOV, and WFRD as of the same snapshot date. Peer selection was made by an agent override of the default peer set (which included integrated oil & gas customers such as XOM and IMO), narrowing to direct oilfield-services and equipment competitors by business-model overlap. The signal layer used to triage the filing — risk-factor classification, debt profile extraction, transcript hedge density, competitive-mention clustering — is MetricDuck's automated pipeline applied to the SEC EDGAR primary documents.

Limitations. The Q1 FY2026 earnings call's full live Q&A session was not retrievable through the standard transcript channels at filing time; the transcript exhibit available on the company's investor-relations CDN is the prepared-remarks PDF, which terminates at the operator's "we can now open the call for questions" handoff. Transcript texture in this article is therefore limited to speaker-labeled prepared-remarks quotations from the CEO and CFO; analyst-exchange verbatim text is not available for this filing. MetricDuck's GAAP operating margin and ROIC for both BKR (89.39% / 85.76%) and SLB (95.00% / 48.28%) are inflated by a known calculation discontinuity in the operating-expense aggregation in newer quarters; the company-reported adjusted EBITDA margin of 17.6% is the correct comparator for narrative purposes, and HAL/FTI/NOV/WFRD numbers in the peer table are unaffected. Shares-outstanding values are null in the MetricDuck XBRL extract for BKR, so market cap and FCF yield in the peer table read as zero or unavailable for BKR; the $68.94 share price (next-day close 2026-04-24) is from MetricDuck's price snapshot. SLB's reported -41.86% TTM revenue growth is a likely data anomaly and is flagged in the peer commentary rather than discounted from the table.

Disclaimer

This article analyzes public SEC filings and earnings materials and does not constitute investment advice, a recommendation to buy or sell any security, or a solicitation. Readers should conduct their own due diligence or consult a licensed advisor before making investment decisions.